SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VAXGEN INC. (VXGN)- The IPO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steven who wrote (39)7/14/1999 10:25:00 PM
From: GPSite  Read Replies (2) of 55
 
Steven,

Your comments are prescient.

Many millions of dollars are spent on Federal grants for AIDS every year.

Scientists compete constantly for these grants. Nobody wants to see their grant money go elsewhere. Most of VaxGen's most vocal opponents have a stake in the money that is doled out -- and for those reasons they do not want to see it succeed.

Part of Don Francis' frustration in the public sector was dealing with these kinds of politics. That's why he went to Genentech in the private sector.

Plain and simple: You will hear a lot of negatives about AIDSVAX. Yet, who else has made it to phase III with an AIDS vaccine? Who is a public company? Who is proceeding forward?

Why did Paul Allen buy 800,000 shares (some on the open market AFTER the IPO)? Is he an idiot? Are his investigators naive?

There is a really good chance that this vaccine will work well enough to be approved by the FDA.

It will change the whole universe of funding. The NIH and CDC are already on VaxGen's side.

History is coming down the track.

GPSite
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext